Oncology

sponsor

Topics in Oncology

Alternative Therapies

Anemia/Polycythemia

Basic Science/Genetics

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

Gynecologic Oncology

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain Management/
Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Soft Tissue/Sarcoma

Transfusion Medicine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Top Ten Searches

brca1

prostate-specific antigen

sclc

fobt

egd

bmi

dysplasia

hematologic

ovarian

hcc

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
Cancer, 07/01/09

Xu MZ et al. - YAP is an independent prognostic marker for overall survival and disease-free survival times of HCC patients and clinicopathologically associated with tumor differentiation and serum AFP level. It is a potential therapeutic target for this aggressive malignancy.

<< Previous
Race does not impact outcome for advanced ovarian cancer patients...

Next >>
Racial and ethnic disparities in the incidence of invasive...

Today in Basic Science/Genetics...keeping you current

Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
Annals of Oncology, 11/02/09

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09

See All of Basic Science/Genetics

Today in Hepatobiliary/Pancreas...keeping you current

Surgical management of hepatocellular carcinoma: Is the jury still out
Surgical Oncology, 11/05/09

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report
World Journal of Surgical Oncology, 11/09/09

See All of Hepatobiliary/Pancreas

Sponsor

Article Search

Sponsor

Sponsor

Send this Summary to a Colleague